Induction chemotherapy in head and neck cancer

Annals of Oncology

Volumn 17, Issue SUPPL. 10, 2006, Pages

  Hitt, R ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CETUXIMAB; CISPLATIN; DOCETAXEL; FLUOROURACIL; PACLITAXEL;

ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CELL COUNT; CERVICAL LYMPH NODE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DISEASE FREE SURVIVAL; DRUG EFFICACY; ENDOSCOPY; GOLD STANDARD; HEAD AND NECK CANCER; HEAD AND NECK SURGERY; HUMAN; INTERMETHOD COMPARISON; LARYNX CANCER; LARYNX SURGERY; LYMPH NODE METASTASIS; MEDICAL DECISION MAKING; MOUTH CANCER; NUCLEAR MAGNETIC RESONANCE IMAGING; OROPHARYNX CANCER; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME; TUMOR CELL; TUMOR VOLUME;

ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; CLINICAL TRIALS; CLINICAL TRIALS AS TOPIC; HEAD AND NECK NEOPLASMS; NEOADJUVANT THERAPY; REMISSION INDUCTION;

EID: 33749621370     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdl234     Document Type: Article

References (17)

1. Ensley JF, Jacobs JR, Weaver A et al. Correlation between response to cisplatinum-combination chemotherapy and subsequent radiotherapy in previously untreated patients with advanced squamous cell cancer of the head and neck. Cancer 1984; 54: 811-814.
2. Enslesy J, Kish J, Tapazoglou E et al. An intensive, five course, alternating combination chemotherapy induction regimen used in patients with advanced, unresectable head and neck cancer. J Clin Oncol 1988; 6: 1147-1153.
3. Hitt R, Lopez Pousa A, Martinez-Trufero J et al. Phase III study comparing cisplatin plus fluourouacil to paclitaxel, cisplatin, and fluourouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer. J Clin Oncol 2005; 23: 8636-8644.
4. Vermorken JB, Remenar E, Van Herpen C et al. Standard cisplatin/ infusional 5-fluourouracil (PF) vs. docetaxel (T) plus PF(TPF) as neoadjuvant chemotherapy for nonresectable locally advanced squamous cell carcinoma of the head and neck (LA-SCCHN): A phase III trial of the EORTC head and neck cancer group. PRO-ASCO 2004; abstr 5508, 490s.
5. Tannock IF. Combined modality treatment with radiotherapy and chemotherapy. Radiother Oncol 1989; 16: 83-101.
6. Tannock IF, Hill RP, eds. The basic science of oncology, ed 2. New York, McGraw-Hill, 1992.
7. Vokes EE, Weichselbaum RR, Lippman SM et al. Head and neck cancer. N Engl J Med 1993; 328: 184-194.
8. Adelstein DJ, TanEH, Lavertu P. Treatment of head and neck cancer: The role of chemotherapy. Crit Rev Oncol Hematol 1996; 24: 97-116.
9. Adelstein DJ, Yl L, Adams GL et al. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol 2003; 21: 92-98.
10. Forastiere AA, Goepfert H, Maor M et al, Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 2003; 349: 2091-2098.
11. The Department of Veteran Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 1991; 324: 1685-1690.
12. Lefebvre JL, Chevalier D, Luboinski B et al. Larynx preservation in pyriform sinus cancer: Preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC head and neck cancer cooperative group. J Natl Cancer Inst 1996; 88: 890-899.
13. Paccagnella A, Orlando A, Marchiori C et al. Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: A study by the Grupo di Studio sui Tumori della testa e del collo. J Natl Cancer Inst 1994; 86: 265-272.
14. Zorat PL, Pacagnella A, Cavaniglia G et al. Randomized phase III trial of neoadjuvant chemotherapy in head and neck cancer. 10-year follow up. J Natl Cancer Inst 2004; 96: 1714-1717.
15. Vokes EE, Weichselbaum RR, Mick R et al. Favourable long-term survival following induction chemotherapy with cisplatin, fluorouracil, and leucovorin and concomitant chemoradiotherapy for locally advanced head and neck cancer. J Natl Cancer Inst 1992; 84: 877-882.
16. Hitt R, Grau JJ, Lopez-Pousa A et al. Phase II/III trial of induction chemotherapy (ICT) with cisplatin/5-fluorouracil (PF) vs. docetaxel (T) plus PF (TPF) followed by chemoradiotherapy (CRT) vs. CRT for unresectable locally advanced head and neck cancer (LAHNC). PRO-ASCO 2005, abstr 5578; 519s.
17. Hitt R, Grau JJ, Lopez-Pousa A et al. Phase II/III trial of induction chemotherapy (ICT) with cisplafin/5-fluorouracil (PF) vs docetaxel (T) plus PF (TPF) followed by chemoradiotherapy (CRT) vs. CRT for unresectable locally advanced head and neck cancer (LAHNC). PRO-ASCO 2006.